Biomarkers for predicting taxane efficacy in ER+/HER2-breast cancer patients: From in-vitro chemosensitivity screening to clinical validation in the GEICAM/ 9906 trial
Date issued
2013Journal title
EUROPEAN JOURNAL OF CANCER
Type of content
Publicación de congreso